Neurotropin reverses paclitaxel-induced neuropathy without affecting anti-tumour efficacy

European Journal of Cancer

Volumn 45, Issue 1, 2009, Pages 154-163

  Kawashiri, Takehiro ^a   Egashira, Nobuaki ^a   Itoh, Yoshinori ^b   Shimazoe, Takao ^c   Ikegami, Yoko ^a   Yano, Takahisa ^a   Yoshimura, Megumu ^d   Oishi, Ryozo ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b GIFU UNIVERSITY HOSPITAL   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Allodynia; Anti tumour activity; Neurite outgrowth; Neuropathy; Neurotropin; Paclitaxel

Indexed keywords

NEUROTROPIN; PACLITAXEL;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; GRIP STRENGTH; HYPERALGESIA; MALE; MOTOR DYSFUNCTION; MOUSE; NERVE FIBER DEGENERATION; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SPINAL GANGLION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AXONS; CELL LINE, TUMOR; COLD TEMPERATURE; HYPERALGESIA; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEOPLASM TRANSPLANTATION; NEURITES; PACLITAXEL; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYSACCHARIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 57649178652     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.10.004     Document Type: Article

References (46)

1. Quasthoff S., and Hartung H.P. Chemotherapy-induced peripheral neuropathy. J Neurol 249 (2002) 9-17
2. Dougherty P.M., Cata J.P., Cordella J.V., Burton A., and Weng H.R. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 109 (2004) 132-142
3. Lee J.J., and Swain S.M. Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol 24 (2006) 1633-1642
4. Lorusso D., Ferrandina G., Greggi S., et al. Multicenter Italian Trials in Ovarian Cancer investigators. Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients. Ann Oncol 14 (2003) 1086-1093
5. Stubblefield M.D., Vahdat L.T., Balmaceda C.M., Troxel A.B., Hesdorffer C.S., and Gooch C.L. Glutamine as a neuroprotective agent in highdose paclitaxel-induced peripheral neuropathy: A clinical and electrophysiologic study. Clin Oncol (R Coll Radiol) 17 (2005) 271-276
6. Bianchi G., Vitali G., Caraceni A., et al. Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine. Eur J Cancer 41 (2005) 1746-1750
7. Takeda K., Negoro S., and Matsui K. Phase I safety and pharmacokinetic trial of BNP7787 in patients receiving cisplatin (CDDP) and paclitaxel (PTX) for advanced non-small cell lung cancer (NSCLC): An Osaka phase I study group trial. Proc Am Soc Clin Oncol 21 (2002) 114
8. Argyriou A.A., Chroni E., Koutras A., et al. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: A randomized controlled trial. Neurology 64 (2005) 26-31
9. Bárdos G., Móricz K., Jaszlits L., et al. BGP-15, a hydroximic acid derivative, protects against cisplatin or taxol-induced peripheral neuropathy in rats. Toxicol Appl Pharmacol 190 (2003) 9-16
10. Siau C., and Bennett G.J. Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy. Anesth Analg 102 (2006) 1485-1490
11. Matsumoto M., Inoue M., Hald A., Xie W., and Ueda H. Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin. J Pharmacol Exp Ther 318 (2006) 735-740
12. Xiao W., Boroujerdi A., Bennett G.J., and Luo Z.D. Chemotherapy-evoked painful Peripheral neuropathy: analagesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit. Neuroscience 144 (2007) 714-720
13. Alessandri-Haber N., Dina O.A., Yeh J.J., Parada C.A., Reichling D.B., and Levine J.D. Transient receptor potential vanilloid 4 is essential in chemotherapy-induced neuropathic pain in the rat. J Neurosci 24 (2004) 4444-4452
14. Flatters S.J.L., and Bennett G.J. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 122 (2006) 245-257
15. Peters C.M., Jimenez-Andrade J.M., Jonas B.M., et al. Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells. Exp Neurol 203 (2006) 42-54
16. Ledeboer A., Jekich B.M., Sloane E.M., et al. Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav Immun 21 (2006) 686-698
17. Siau C., Xiao W., and Bennett G.J. Paclitaxel- and vincristine-evoked painful peripheral neuropathies: Loss of epidermal innervation and activation of Langerhans cells. Exp Neurol 201 (2006) 507-514
18. Sahenk Z., Barohn R., New P., and Mendell J.R. Taxol neuropathy: Electrodiagnostic and sural nerve biopsy findings. Arch Neurol 51 (1994) 726-729
19. New P.Z., Jackson C.E., Rinaldi D., Burris H., and Barohn R.J. Peripheral neuropathy secondary to docetaxel (Taxotere). Neurology 46 (1996) 108-111
20. Fazio R., Quattrini A., Bolognesi A., et al. Docetaxel neuropathy: a distal axonopathy. Acta Neuropathol (Berl) 98 (1999) 651-653
21. 2 receptors in spinal dorsal horn. Life Sci 62 (1998) 2181-2190
22. Flatters S.J.L., and Bennett G.J. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 109 (2004) 150-161
23. Authier N., Gillet J.P., Fialip J., Eschalier A., and Coudore F. Description of a short-term Taxol®-induced nociceptive neuropathy in rats. Brain Res 887 (2000) 239-249
24. Jeljeli M., Strazielle C., Caston J., and Lalonde R. Effects of centrolateral or medial thalamic lesions on motor coordination and spatial orientation in rats. Neurosci Res 38 (2000) 155-164
25. Flatters S.J.L., Xiao W.H., and Bennett G.J. Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy. Neurosci Lett 397 (2006) 219-223
26. Fritz I.B., and Yue K.T. Long-chain carnitine acyltransferase and the role of acylcarnitine derivatives in the catalytic increase of fatty acid oxidation induced by carnitine. J Lipid Res 58 (1963) 279-288
27. Gee N.S., Brown J.P., Dissanayake V.U., Offord J., Thurlow R., and Woodruff G.N. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 271 (1996) 5768-5776
28. Backonja M., Beydoun A., Edwards K.R., et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280 (1998) 1831-1836
29. Gorson K.C., Schott C., Herman R., Ropper A.H., and Rand W.M. Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatry 66 (1999) 251-252
30. Caraceni A., Zecca E., Bonezzi C., et al. Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 22 (2004) 2909-2917
31. Rowbotham M., Harden N., Stacey B., Bernstein P., and Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280 (1998) 1837-1842
32. Dina O.A., Chen X., Reichling D., and Levine J.D. Role of protein kinase Cε and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat. Neuroscience 108 (2001) 507-515
33. Polomano R.C., Mannes A.J., Clark U.S., and Bennett G.J. A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 94 (2001) 293-304
34. Cliffer K.D., Siuciak J.A., Carson S.R., et al. Physiological characterization of taxol-induced large-fiber sensory neuropathy in the rat. Ann Neurol 43 (1998) 46-55
35. Wang M.S., Davis A.A., Culver D.G., Wang Q., Powers J.C., and Glass J.D. Calpain inhibition protects against Taxol-induced sensory neuropathy. Brain 127 (2004) 671-679
36. Wagner R., Heckman H.M., and Myers R.R. Wallerian degeneration and hyperalgesia after peripheral nerve injury are glutathione-dependent. Pain 77 (1998) 173-179
37. Wang M.S., Davis A.A., Culver D.G., and Glass J.D. WldS mice are resistant to paclitaxel (taxol) neuropathy. Ann Neurol 52 (2002) 442-447
38. Nakamura K., Ono T., Nishijo H., and Tamura R. Action of neurotropin on rat hypothalamic neurons in tissue slices. Brain Res Bull 24 (1990) 811-817
39. Hata T., Kita T., Kawabata A., Itoh E., and Nishimura Y. Changes of tissue blood flow in mice loaded with SART (repeated cold) stress or restraint and water immersion stress and the effect of administered neurotropin. Jpn J Pharmacol 41 (1986) 69-79
40. Yoneda R., Kita T., Hata T., and Namimatsu A. Experimental partial sympathicotonia, and effects of some drugs on it in restraint and water immersion stressed animals. J Pharmacobiodyn 3 (1980) 692-701
41. Hata T., Kita T., Higashiguchi T., and Ichida S. Total acetylcholine content, and activities of choline acetyltransferase and acetylcholinesterase in brain and duodenum of SART-stressed (repeated cold-stressed) rat. Jpn J Pharmacol 41 (1986) 475-485
42. Tanaka M., Ida Y., Tsuda A., and Tsujimaru S. Effects of neurotropin on regional brain noradrenaline metabolism in rats. Jpn J Pharmacol 49 (1989) 187
43. Hoshino Y., Nakamura T., Sato A., Mishima M., Yodoi J., and Nakamura H. Neurotropin demonstrates cytoprotective effects in lung cells through the induction of thioredoxin-1. Am J Respir Cell Mol Biol 37 (2007) 438-446
44. Bai J., Nakamura H., Kwon Y.W., et al. Critical roles of thioredoxin in nerve growth factor-mediated signal transduction and neurite outgrowth in PC12 cells. J Neurosci 23 (2003) 503-509
45. Price S.A., Gardiner N.J., Duran-Jimenez B., Zeef L.A., Obrosova I.G., and Tomlinson D.R. Thioredoxin interacting protein is increased in sensory neurons in experimental diabetes. Brain Res 1116 (2006) 206-214
46. Schulze P.C., Yoshioka J., Takahashi T., He Z., King G.L., and Lee R.T. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 279 (2004) 30369-30374